ThursdayApr 18, 2024 10:00 am

Therapist Explains What Psychedelics Do, What Talk Therapy Can’t

Interest in the use of psychedelics in therapy has increased over the last couple of years, with researchers finding that drugs such as psilocybin, LSD and ketamine may be useful in the treatment of different mental-health conditions. According to one therapist, psychedelics are drugs that enable the dissolution of the individual ego. This is the objective of many spiritual traditions, where one realizes that they aren’t an individual island living a separate life but a smaller cog in a huge machine. By the aforementioned definition, psychedelics include ayahuasca, DMT, ketamine, psilocybin and LSD. It is important to note MDMA is…

Continue Reading

TuesdayApr 16, 2024 10:00 am

AMA Study Finds Treating Mental-Health Issues with Psilocybin Doesn’t Increase Paranoia Risk

A recently published review has determined that using psilocybin to manage mental-health conditions doesn’t heighten the risk of paranoia. This discovery comes at a time when public interest in the therapeutic potential of psychedelics is increasing. The review was carried out by researchers at Larkin University, the University of Georgia and Palm Beach Atlantic University, who were focused on better understanding the potential negative effects of psilocybin therapy. For their study, the researchers reviewed six randomized, double-blind clinical trials with a total of 528 patients, where psilocybin was administered to treat depression and anxiety. They used ClinicalTrials.gov, Web of Science…

Continue Reading

ThursdayApr 11, 2024 10:00 am

Psilocybin Could Help in Combating Diabetes

Diabetes is a chronic illness characterized by high levels of blood sugar. There are different types of diabetes, the most common being types I and II. Latest data estimates that by 2045, more than 700 million individuals globally could be afflicted with the illness as its prevalence continued to rise. Researchers have commenced studies into whether psilocybin may help fight the effects of diabetes. Psilocybin is the primary psychoactive compound found in various species of hallucinogenic mushrooms. In the last couple of years, the compound’s therapeutic potential has been recognized, particularly for mental health disorders such as anxiety, depression and…

Continue Reading

TuesdayApr 09, 2024 10:00 am

Missouri to Use $10M from Opioid Funds to Study Psilocybin

Legislators in the House of Representatives in the state of Missouri have awarded preliminary approval to a budget measure that would allocate $10 million from opioid settlement funds to study grants focused on researching psilocybin’s use in treating opioid-use disorder. The initiative, HB 2010, was amended in the House. One amendment made in a committee last week would have allocated the $10 million toward conducting research on ibogaine as an opioid-use disorder treatment. This provision was modified to fund studies on psilocybin instead. Ibogaine’s addition to HB 2010 was facilitated by Representative Chad Perkins, a long-time law enforcement officer. The…

Continue Reading

ThursdayApr 04, 2024 10:00 am

More Psychedelic Users Reporting Symptoms of HPPD

Hallucinogenic persistent perception disorder (HPPD) is an intoxication disorder caused by psychedelic drugs that encompasses a range of visual disturbances that occur in different time frames. The disorder also causes extreme anxiety as well as out-of-body sensations and is marked by shame as well as stigma. There are two types of HPPD; the first is characterized by brief flashbacks, while individuals with the second type of HPPD experience symptoms that can last anywhere between a couple of months to their whole lives. Dr. Anneliese McConnell, a researcher at Western Sydney University, reports that HPPD affects more than 5% of psychedelic…

Continue Reading

TuesdayApr 02, 2024 10:00 am

Research Findings Promising as Scientists Study Placebo Effect in Psychedelic Treatment

Recent research assessed how patient expectations influenced the outcomes of psychedelic treatments in comparison to conventional treatments. This comes as the global impact of depression is being felt in different parts of the world and the need for alternative treatments increases. For a long time, selective serotonin re-uptake inhibitors (SSRIs) have been prescribed to manage depression. While these drugs do perform better than placebos, they aren’t effective for all individuals. Psychedelic-assisted therapy has been heralded as a new approach to manage mental-health conditions such as depression, promising a range of benefits with only a few sessions. However, some questions on…

Continue Reading

PsychedelicNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 415.949.5050